Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03465306
Other study ID # ObesityCBT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 18, 2017
Est. completion date April 30, 2018

Study information

Verified date April 2019
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present study is to develop and validate the effects of a new cognitive behavioral therapy (CBT) using digital healthcare mobile apps such as Noom Coach and InBody.


Description:

Seventy female participants whose BMI scores were above 23 and who had no other clinical problem except obesity were randomized into an experimental and a control group. Forty-five people in the experimental group were connected with the therapist using digital healthcare apps, so they got daily feedbacks and assignments for 8 weeks. Twenty-five people in the control group also used digital healthcare apps but they were asked to do self-care without intervention.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date April 30, 2018
Est. primary completion date April 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years to 39 Years
Eligibility Inclusion Criteria:

- SIMS score ranks over high 20% of total

Exclusion Criteria:

- Had been prescribed with psychological problems or medical problems.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Behavioral Therapy
Cognitive-behavioral therapy is a psycho-social intervention that is the most widely used evidence-based practice for improving mental health and requires active interactions between the participants and a therapist or coach.
Device:
Self-guided
Self-guided refers to any contact between the participants and a therapist or coach.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (3)

Lead Sponsor Collaborator
Seoul National University Hospital InBody, Noom Inc.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Weight difference Baseline, at 8 weeks, at 6 months
Secondary weight and height will be combined to report BMI in kg/m^2 BMI difference Baseline, at 8 weeks, at 6 months
Secondary Fat percent Fat percent difference Baseline, at 8 weeks, at 6 months
Secondary Rosenberg Self-Esteem Scale (RSES). Child / Adolescent Measures Psychological index, total scores range from 10~40, higher the score lower the self-esteem. Baseline, at 8 weeks, at 6 months
Secondary Body Shape Questionnaire: Psychometric properties of the short version (BSQ-8C) Psychological index, total scores range from 8~48, higher the score lower the satisfaction to self-body image. Baseline, at 8 weeks, at 6 months
Secondary Dutch Eating Behavior Questionnaire (DEBQ) Psychological index, total scores range from 33~165, higher the score more problems in eating behavior. Baseline, at 8 weeks, at 6 months
Secondary Yale Food Addiction Scale (YFAS) Psychological index, total scores range from 0~7, higher the score more expected to have food addiction. Baseline, at 8 weeks, at 6 months
Secondary Trait Anxiety Inventory (TAI) Psychological index, total scores range from 20~80, higher the score higher in feelings of anxiety. Baseline, at 8 weeks, at 6 months
Secondary Korean Beck Depression Inventory (K-BDI) Psychological index, total scores range from 0~63, higher the score higher in feelings of depressed. Baseline, at 8 weeks, at 6 months
Secondary Automatic Thoughts Questionnaire-30 (ATQ-30) Psychological index, total scores range from 30~150, higher the score higher tendency to have negative automatic thoughts. Baseline, at 8 weeks, at 6 months
Secondary the result of cholesterol total Biological index Baseline, at 8 weeks
Secondary the result of triglycerides (TG) Biological index Baseline, at 8 weeks
Secondary the result of gamma-glutamyl transferase (GGT) Biological index Baseline, at 8 weeks
Secondary the result of glucose Biological index Baseline, at 8 weeks
Secondary the result of alanine aminotransferase (ALT) Biological index Baseline, at 8 weeks
Secondary the result of aspartate aminotransferase (AST) Biological index Baseline, at 8 weeks
Secondary the result of insulin Biological index Baseline, at 8 weeks
Secondary the result of leptin Biological index Baseline, at 8 weeks
Secondary Buffet index Buffet test, total scores range from 0~100, higher the score better in healthy food choice and amount of intake. Baseline, at 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT03023579 - The Star Excursion Balance Test: Analysis of Children With Cerebral Palsy N/A